Tarsons Products Ltd Share Price – NSE /  BSE

Healthcare, Small Cap

Net profit of Tarsons Products declined 59.02% to Rs 4.18 crore in the quarter ended March 2026 as against Rs 10.20 crore during the previous quarter ended March 2025. Sales rose 7.31% to Rs 120.93 crore in the quarter ended March 2026 as against Rs 112.69 crore during the previous quarter ended March 2025.

For the full year,net profit declined 51.90% to Rs 14.32 crore in the year ended March 2026 as against Rs 29.77 crore during the previous year ended March 2025. Sales rose 7.67% to Rs 422.51 crore in the year ended March 2026 as against Rs 392.41 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Tarsons Products will hold a meeting of the Board of Directors of the Company on 22 May 2026.

The board of Tarsons Products at its meeting held on 06 February 2026 has approved equity infusion of further EUR 3 Million in its wholly-owned subsidiary, Tarsons Life Science, a company incorporated in Singapore for meeting its operational and financial expenses.

Powered by Capital Market - Live News

The board of Tarsons Products at its meeting held on 06 February 2026 has approved the appointment of Vinesh Mohan Kriplani (DIN: 08212644) as an Additional Director (Category: Non-Executive Independent Director). The board also accepted the resignation of Girish Paman Vanvari (DIN:07376482) as an Independent Director of the Company.

Powered by Capital Market - Live News